CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Senior Vice President, Finance sold 897 shares at $5.49 ($4,925)
- 4 Open-market sale See Remarks sold 7,162 shares at $5.49 ($39,319)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Technology Officer sold 2,151 shares at $7.75 ($16,670)
- 4 Open-market sale Senior Vice President, Finance sold 1,404 shares at $7.75 ($10,881)
Page 7 of 20 · 383 filings